Kevin Michael Brindle | |
|---|---|
| Born | 27 August 1955 |
| Alma mater | University of Oxford |
| Known for | Magnetic resonance imaging |
| Scientific career | |
| Fields | |
| Institutions | |
| Website | Official website  |
Kevin Michael Brindle, FMedSci, FRS (born 27 August 1955)[1] is a British biochemist, currently Professor of Biomedical Magnetic Resonance in the Department of Biochemistry at the University of Cambridge and a Senior Group Leader at Cancer Research UK. He is known for developing magnetic resonance imaging (MRI) techniques for use in cell biochemistry and new imaging methods for early detection, monitoring, and treatment of cancer.[2][3]
- ^ "Brindle, Prof. Kevin Michael". Who's Who. 1 December 2020. doi:10.1093/ww/9780199540884.013.U258373. ISBN 978-0-19-954088-4. Retrieved 8 September 2022.
- ^ "Fellow Detail Page: Kevin Brindle". The Royal Society. Retrieved 8 September 2022.
- ^ "Professor Kevin Brindle". Cancer Research UK. 13 February 2017. Retrieved 8 September 2022.